KYTHERA Biopharmaceuticals to Present at the Bank of America Merrill Lynch 2015 Health Care Conference

WESTLAKE VILLAGE, Calif., May 8, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the Bank of America Merrill Lynch 2015 Health Care Conference.

Event: Bank of America Merrill Lynch 2015 Health Care Conference
Date: Thursday, May 14, 2015
Time: 10:40 a.m. PT

A live webcast will be available under the Investors section of the Company’s website at www.kythera.com. The presentation will be archived on the website and will be available for at least 14 days.


KYTHERA Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. Its lead product, KYBELLA™ (deoxycholic acid), is the first and only approved injectable drug for contouring moderate to severe submental fullness, a condition that is commonly referred to as a double chin. KYTHERA is also developing setipiprant (KYTH-105), an early-stage candidate for the prevention of male pattern baldness. KYTHERA’s longer-term strategy is to leverage its biotechnology and aesthetics experience to expand its product portfolio and pipeline. KYTHERA has submitted regulatory filings for ATX-101 in Canada, Switzerland and Australia. Find more information at www.kythera.com.

Investor Contact: Heather Rowe, Director, Investor Relations Tel: (818) 587- 4559 hrowe@kythera.com

Source:KYTHERA Biopharmaceuticals, Inc.